Cardio Diagnostics Holdings, Inc. Net Income
Cardio Diagnostics Holdings, Inc. (CDIO) reported Net Income of -$1.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$1.50M.
- Cardio Diagnostics Holdings, Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$1.79M.
- Cardio Diagnostics Holdings, Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$1.47M.
- Cardio Diagnostics Holdings, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$1.71M.
- Cardio Diagnostics Holdings, Inc. net income (loss) attributable to parent for fiscal 2025 was -$6.50M.
- Cardio Diagnostics Holdings, Inc. net income (loss) attributable to parent for fiscal 2024 was -$8.38M.
- Cardio Diagnostics Holdings, Inc. net income (loss) attributable to parent for fiscal 2023 was -$8.38M.
- Cardio Diagnostics Holdings, Inc. net income (loss) attributable to parent for fiscal 2022 was -$4.66M.
| Period end | Net Income (Loss) Attributable to Parent 1 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 4 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 7 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.50M 10-Q · filed 2026-08-07 | -$3.29M 10-Q · filed 2026-08-07 | -$4.75M derived: sum of 3 quarters · filed 2026-08-07 | -$6.47M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2026-03-31 | -$1.79M 10-Q · filed 2026-05-15 | -$3.25M derived: sum of 2 quarters · filed 2026-05-15 | -$4.97M derived: sum of 3 quarters · filed 2026-05-15 | -$6.65M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$3.18M derived: sum of 2 quarters · filed 2026-03-13 | -$4.86M derived: sum of 3 quarters · filed 2026-08-07 | -$6.50M 10-K · filed 2026-03-13 | ||||||
| 2025-09-30 | -$1.71M 10-Q · filed 2025-11-12 | -$3.40M derived: sum of 2 quarters · filed 2026-08-07 | -$5.03M 10-Q · filed 2025-11-12 | -$6.55M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-06-30 | -$1.68M 10-Q · filed 2026-08-07 | -$3.32M 10-Q · filed 2026-08-07 | -$4.84M derived: sum of 3 quarters · filed 2026-08-07 | -$6.25M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-03-31 | -$1.64M 10-Q · filed 2026-05-15 | -$3.15M derived: sum of 2 quarters · filed 2026-05-15 | -$4.57M derived: sum of 3 quarters · filed 2026-05-15 | -$5.85M derived: sum of 4 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$2.93M derived: sum of 2 quarters · filed 2026-03-13 | -$4.22M derived: sum of 3 quarters · filed 2026-03-13 | -$8.38M 10-K · filed 2026-03-13 | ||||||
| 2024-09-30 | -$1.41M 10-Q · filed 2025-11-12 | -$2.70M derived: sum of 2 quarters · filed 2025-11-12 | -$6.86M 10-Q · filed 2025-11-12 | -$8.25M derived: sum of 4 quarters · filed 2025-11-12 | ||||||
| 2024-06-30 | -$1.29M 10-Q · filed 2025-08-14 | -$5.45M 10-Q · filed 2025-08-14 | -$6.84M derived: sum of 3 quarters · filed 2025-08-14 | -$8.77M derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | -$4.16M 10-Q · filed 2025-05-15 | -$5.55M derived: sum of 2 quarters · filed 2025-05-15 | -$7.48M derived: sum of 3 quarters · filed 2025-05-15 | -$11.51M derived: sum of 4 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$3.32M derived: sum of 2 quarters · filed 2025-03-20 | -$7.34M derived: sum of 3 quarters · filed 2025-03-20 | -$8.38M 10-K · filed 2025-03-20 | ||||||
| 2023-09-30 | -$1.93M 10-Q · filed 2024-11-13 | -$5.96M derived: sum of 2 quarters · filed 2024-11-13 | -$6.99M 10-Q · filed 2024-11-13 | -$9.37M derived: sum of 4 quarters · filed 2024-11-13 | ||||||
| 2023-06-30 | -$4.02M 10-Q · filed 2024-08-12 | -$5.06M 10-Q · filed 2024-08-12 | -$7.43M derived: sum of 3 quarters · filed 2024-08-12 | -$8.58M derived: sum of 4 quarters · filed 2024-08-12 | ||||||
| 2023-03-31 | -$1.03M 10-Q · filed 2024-05-15 | -$3.41M derived: sum of 2 quarters · filed 2024-05-15 | -$4.56M derived: sum of 3 quarters · filed 2024-05-15 | -$5.40M derived: sum of 4 quarters · filed 2024-05-15 | ||||||
| 2022-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$3.53M derived: sum of 2 quarters · filed 2024-04-01 | -$4.37M derived: sum of 3 quarters · filed 2024-04-01 | -$4.66M 10-K · filed 2024-04-01 | ||||||
| 2022-09-30 | -$1.15M 10-Q · filed 2023-11-13 | $202.27K 10-Q · filed 2022-11-07 | -$1.99M derived: sum of 2 quarters · filed 2023-11-13 | -$2.28M 10-Q · filed 2023-11-13 | -$513.04K 10-Q · filed 2022-11-07 | |||||
| 2022-06-30 | -$842.00K 10-Q · filed 2023-11-13 | -$492.65K 10-Q · filed 2022-08-10 | -$1.13M 10-Q · filed 2023-08-14 | -$715.31K 10-Q · filed 2022-08-10 | ||||||
| 2022-03-31 | -$290.06K 10-Q · filed 2023-11-13 | -$222.66K 10-Q · filed 2022-05-12 | ||||||||
| 2021-12-31 | -$144.84K 10-K · filed 2022-03-31 | -$620.45K 10-K · filed 2023-03-31 | ||||||||
| 2021-09-30 | -$721.00 10-Q · filed 2022-11-07 | |||||||||
| 2021-06-30 | -$397.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |